The replication structure of the human dystrophin gene in cultured masculine erythroleukemia cells (line HEL 92.1.7) was studied using the replication direction assay. This gene is organized into at least six replicons ranging in size from 170 to more than 500 kb. One of the replicon junctions (sites of replication termination) was mapped to intron 44, i.e., roughly in the same area where the major recombination hot spot is located. A replicon junction was also found between the muscle and the brain promoters. The two replicons mapped in the present study are highly asymmetric, as the distances covered by the replication forks moving in opposite directions from the same origin differ by more than threefold.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1006/geno.1997.4875 | DOI Listing |
Alzheimers Dement
December 2024
Radboud University Medical Center, Nijmegen, Gelderland, Netherlands.
Background: Commissural tracts are the white matter fibre bundles intercommunicating left and right brain hemispheres. They integrate many cognitive functions such as memory, verbal processing, motor and perceptual skills. Also, commissures connect specific layers of cortical neurons that are also lost in Alzheimer's disease (AD) and other neurodegenerative disorders.
View Article and Find Full Text PDFEnviron Sci Technol
January 2025
Faculty of Agriculture, Life, and Environmental Sciences, Zhejiang University, Hangzhou 310058, China.
Electron release and transfer are pivotal to the efficiency of multiple biogeochemical and pollutant processes. Despite substantial efforts to develop electron-transfer characterization techniques, visualization of electron transfer remains challenging. This study introduces an innovative strategy for mapping electron-transfer distance using nanoscale zerovalent iron (nZVI) as a case study.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
Cognition Therapeutics, Inc, Pittsburgh, PA, USA.
Background: SHINE (NCT03507790, COG0201) is a Phase 2 randomized, double-blind, placebo-controlled 6-month trial, conducted to study the effect of the sigma-2 receptor (S2R) modulator CT1812 in patients with Alzheimer's disease (AD). An unbiased assessment of CSF proteomes from the patients that completed the SHINE trial was performed to identify pharmacodynamic (PD) biomarkers of target/pathway engagement and disease modification for CT1812.
Method: Tandem-mass tag mass spectrometry (TMT-MS) CSF proteomics was performed on baseline and end of study samples from an analysis of SHINE Part A and B to test the effects of two doses (100 mg, 300 mg; given orally, once daily) of CT1812 compared to placebo in mild to moderate AD patients.
Alzheimers Dement
December 2024
Radboud University Medical Center, Nijmegen, Gelderland, Netherlands.
Background: Commissural tracts are the white matter fibre bundles intercommunicating left and right brain hemispheres. They integrate many cognitive functions such as memory, verbal processing, motor and perceptual skills. Also, commissures connect specific layers of cortical neurons that are also lost in Alzheimer's disease (AD) and other neurodegenerative disorders.
View Article and Find Full Text PDFBackground: Although investment in biomedical and pharmaceutical research has increased significantly over the past two decades, there are no oral disease-modifying treatments for Alzheimer's disease (AD).
Method: We performed comprehensive human genetic and multi-omics data analyses to test likely causal relationship between EPHX2 (encoding soluble epoxide hydrolase [sEH]) and risk of AD. Next, we tested the effect of the oral administration of EC5026 (a first-in-class, picomolar sEH inhibitor) in a transgenic mouse model of AD-5xFAD and mechanistic pathways of EC5026 in patient induced Pluripotent Stem Cells (iPSC) derived neurons.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!